Let's Talk Innovation

Let's Talk
Innovation

You are here

Early-Stage Life Sciences Companies in New York and Seattle Get Support Through New Collaboration with Accelerator Corporation

Boston
Innovation Center July 29th, 2014

Developing strong syndicates to support early-stage, innovative companies is an important part of our work, which is why today we are pleased to announce a new collaboration with Accelerator Corporation, a biotechnology investment and management company that is supporting life science company formation in Seattle and New York.

Through Johnson & Johnson Development Corporation’s investment, we have joined a syndicate of life science investors to fully fund Accelerator Corporation’s fourth commitment round.  With this new round, Accelerator is expanding from Seattle to New York, where there is significant opportunity to support early-stage opportunities.

Since its formation in 2003, Accelerator has incubated 12 early-stage biotechnology companies, providing them with the critical management and financial resources necessary to further develop important science.   Accelerator has demonstrated a track record of success, with half of these 12 companies graduating from Accelerator’s incubation infrastructure.  Additionally, two have been acquired, and a third has raised additional funding.

Accelerator has also developed important partnerships with leading research institutions, and we are pleased to be supporting them through this additional program.

In New York City, Accelerator will work in partnership with Albert Einstein College of Medicine of Yeshiva University, Columbia University, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, New York University, The Rockefeller University, and Weill Cornell Medical College.

In Seattle, Accelerator has expanded its partners beyond the Institute for Systems Biology to include Benaroya Research Institute at Virginia Mason, Infectious Disease Research Institute, Pacific Northwest Diabetes Research Institute, Puget Sound Blood Center Research Institute, Seattle BioMed, Seattle Children’s Research Institute and Washington State University.

Today, more than ever, it is important to work through traditional as well as new models to support innovation, and our collaboration with Accelerator demonstrates the breadth of programs we are engaged in to support entrepreneurs.

See Wall Street Journal Article

See Entreprenuer Magazine Article

 

 

Add new comment

Leave a comment

You agree that the information you provide will be governed by our Privacy Policy.
Your email address and last name will not be displayed publicly with your comment.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

We reserve the right to not post any comment that is considered inappropriate, off-topic, abusive, or that is used to promote and solicit for third party sites, initiatives, or products. All comments will be reviewed and may not be posted if deemed inappropriate. Approved comments may take up to 72 hours after they are received to be posted.

This Blog is not intended to be a place to report customer service, adverse events or product quality complaints. We take adverse events and product quality complaints very seriously. To report an adverse event or product quality complaint, please send us a message at jnjinnovation@its.jnj.com.